Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

CureVac: History, Technology & Companies

CureVac is a biopharmaceutical company based in Tübingen, Germany that develops therapies based on messenger RNA (mRNA). With approximately 375 employees in 2018, it was founded in 2000 by Ingmar Hoerr, Steve Pascolo, Florian von der Mulbe, Günther Jung, and Hans-Georg Rammensee.

Language: English [EN]
Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.
100%
More settings
100% 100% 100% 100% 100%

CureVac topic overview

The analysis highlights History, Technology and Companies as prominent areas in the source structure around CureVac.

Related topics
53
Source areas
3
Connected nodes
56
Extracted relationships
72
Concept neighborhoods
18
Bridge connections
56

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

History · 29 topics
Overview · 16 topics
COVID-19 vaccine candidate · 8 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

Founded
2000; 26 years ago (2000)
Founders
Ingmar Hoerr Steve Pascolo Florian von der Muelbe Günther Jung Hans-Georg Rammensee
Industry
Biotechnology
Headquarters
Tübingen, Germany
Key people
Franz-Werner Haas (CEO) Steve Pascolo (CSO) Florian von der Mulbe (COO)
Number of employees
< 700

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

History

COVID-19 vaccine candidate

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How CureVac connects Entity context

The extracted context around CureVac shows recurring relationship patterns in the source. For example, CureVac → According, CEO, CureVac AG's CEO Daniel, German, Ingmar Hoerr, March, Menichella, On, President Donald Trump, Sonntag, Task Force, To, Trump, Twitter, United States, US, Welt, White House Another extracted example is CureVac → As, Bayer, COVID-19, CVnCoV, December, EMA, European Medicines Agency, European Medicines Agency's, February, In December, In January, June, On, Phase III, This. Use these groups to spot repeated connection types before inspecting the individual relationships.

CureVac

Top relations

related to Reports of Trump administration overtures · 18
CureVac → According, CEO, CureVac AG's CEO Daniel, German, Ingmar Hoerr, March, Menichella, On, President Donald Trump, Sonntag, Task Force, To, Trump, Twitter, United States, US, Welt, White House
related to COVID-19 vaccine candidate · 15
CureVac → As, Bayer, COVID-19, CVnCoV, December, EMA, European Medicines Agency, European Medicines Agency's, February, In December, In January, June, On, Phase III, This
related to Research collaborations · 11
CureVac → Also, Baden-Württemberg, Cancer Research Institute, Handelsblatt, In, In October, Janssen Pharmaceuticals Inc, Johnson, Ludwig Cancer Research, Weconomy, Wissensfabrik
related to Investment · 7
CureVac → August, By, CVAC, In June, KfW, NASDAQ, On
related to Acquisition · 5
CureVac → BioNTech, Curevac's, In June, On December, US
related to External links · 5
CureVac → GoogleReutersSEC, Media, Official, Wikimedia Commons, Wiktionary-logo-en-v2
Founded · 1
CureVac → 2000; 26 years ago (2000)
Founders · 1
CureVac → Ingmar Hoerr Steve Pascolo Florian von der Muelbe Günther Jung Hans-Georg Rammensee
Headquarters · 1
CureVac → Tübingen, Germany
Industry · 1
CureVac → Biotechnology

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

vaccine announced company cvncov covid-19 mrna clinical 2020 phase vaccines develop million iii technology approximately june government candidate germany 2021

CureVac relationships Subject–Predicate–Object triples

TTTA extracted 72 structured relationships around CureVac. Examples in this analysis include CureVac → Founded → 2000; 26 years ago (2000) and CureVac → Founders → Ingmar Hoerr Steve Pascolo Florian von der Muelbe Günther Jung Hans-Georg Rammensee. The table shows each extracted connection, where it came from and its confidence.

SubjectPredicateObjectConfidenceSrc
CureVacFounded2000; 26 years ago (2000)1.00infobox
CureVacFoundersIngmar Hoerr Steve Pascolo Florian von der Muelbe Günther Jung Hans-Georg Rammensee1.00infobox
CureVacHeadquartersTübingen, Germany1.00infobox
CureVacIndustryBiotechnology1.00infobox
CureVacKey peopleFranz-Werner Haas (CEO) Steve Pascolo (CSO) Florian von der Mulbe (COO)1.00infobox
CureVacNumber of employees< 7001.00infobox
CureVacTotal equity€1.40 billion (October 2017)1.00infobox
CureVacTraded asNasdaq: CVAC1.00infobox
CureVacTypePublic1.00infobox
CureVacWebsitewww.curevac.com1.00infobox
CureVacis abiopharmaceutical company based in Tübingen0.90text
CureVacrelated to AcquisitionIn June0.60section

Related concept clusters Concept neighborhoods

The concept neighborhoods around CureVac bring nearby vocabulary together. In this analysis, examples include Vaccine, Announced and Covid-19. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

  • CureVac
    • Vaccine
    • Announced
    • Covid-19
    • Million
    • Develop
    • Approximately
    • Development
    • Government
    • June
    • March
    • Clinical
    • Vaccines
  • curevac
    • Vaccine
    • Announced
    • Covid-19
    • Million
    • Develop
    • Approximately
    • Development
    • Government
    • June
    • March
    • Clinical
    • Vaccines
  • curevac covid-19 vaccine (cvncov)
    • Vaccine
    • Agreement
    • German
    • Iii
    • Cvncov
    • Phase
    • Announced
    • Covid-19
    • Curevac
    • Technology
    • Million
    • Candidate
  • eli lilly and company
    • Development
    • Vaccines
    • Mrna
    • Cvncov
    • October
    • Vaccine
    • Began
    • Germany
    • Government
    • Technology
    • Curevac
    • Clinical
  • pharmaceutical company
    • Development
    • Vaccines
    • Mrna
    • Cvncov
    • October
    • Vaccine
    • Began
    • Germany
    • Government
    • Technology
    • Curevac
    • Clinical
  • covid-19 vaccine candidate
    • Vaccine
    • Agreement
    • German
    • Cvncov
    • Curevac
    • Technology
    • Candidate
    • Covid-19
    • Develop
    • Phase
    • Clinical
    • Ceo
  • covid-19 pandemic
    • Vaccine
    • Agreement
    • German
    • Cvncov
    • Curevac
    • Candidate
    • Develop
    • Clinical
    • Announced
    • Ceo
    • Research
    • Rna
  • covid-19
    • Vaccine
    • Agreement
    • German
    • Cvncov
    • Curevac
    • Candidate
    • Develop
    • Clinical
    • Announced
    • Ceo
    • Research
    • Rna

Connections between topic areas Semantic bridges

For CureVac, one of the stronger structural bridges in this analysis connects CureVac with History. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3
CureVac — History · splits 27 ⟂ 30
CureVac — Overview · splits 40 ⟂ 17
CureVac — COVID-19 vaccine candidate · splits 48 ⟂ 9

Map overview Semantic statistics

CureVac

Nodes57
Edges56
Triples72
Avg. degree1.96
Density0.035088
Components1

Source & methodology

TTTA analyzes the structure around CureVac to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Technology & Companies, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — CureVac · EN edition · Analysis: TopicsToTalkAbout

For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.